SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-22-021620
Filing Date
2022-09-01
Accepted
2022-09-01 07:05:18
Documents
15
Period of Report
2022-08-31
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K vxrt20220831_8k.htm   iXBRL 8-K 28301
2 EXHIBIT 99.1 ex_419074.htm EX-99.1 24223
3 EXHIBIT 99.2 ex_419075.htm EX-99.2 13081
  Complete submission text file 0001437749-22-021620.txt   209450

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA vxrt-20220831.xsd EX-101.SCH 3600
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vxrt-20220831_def.xml EX-101.DEF 11531
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE vxrt-20220831_lab.xml EX-101.LAB 15413
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vxrt-20220831_pre.xml EX-101.PRE 11687
9 EXTRACTED XBRL INSTANCE DOCUMENT vxrt20220831_8k_htm.xml XML 2558
Mailing Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35285 | Film No.: 221219627
SIC: 2836 Biological Products, (No Diagnostic Substances)